We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Deaths and Cardiovascular Events in Men Receiving Testosterone—Reply

P. Michael Ho, MD, PhD1; Anna E. Barón, PhD1; Margaret E. Wierman, MD1
[+] Author Affiliations
1VA Eastern Colorado Health Care System, Denver
JAMA. 2014;311(9):964-965. doi:10.1001/jama.2014.401.
Text Size: A A A
Published online


In Reply The study objective was to assess the association of testosterone use with patient outcomes using observational data from clinical practice. Because treatment with testosterone was not randomized, drawing conclusions based on raw event numbers in patients not receiving treatment vs those receiving treatment is not valid.

To account for differences in follow-up (659 940 days of follow-up for treated vs 6 653 821 days for untreated) and the timing of testosterone therapy initiation, we applied Kaplan-Meier methods with testosterone therapy initiation as a time-varying covariate, which considers patients as receiving therapy once they fill an initial prescription (median of 531 days after angiography [time 0]). This contrasts with the standard methods of categorizing use of testosterone therapy at baseline based on whether patients start therapy at any time during follow-up, which incorrectly classifies patients as receiving therapy before they receive it and attenuates treatment effects.1


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




November 6, 2013
Rebecca Vigen, MD, MSCS; Colin I. O’Donnell, MS; Anna E. Barón, PhD; Gary K. Grunwald, PhD; Thomas M. Maddox, MD, MSc; Steven M. Bradley, MD, MPH; Al Barqawi, MD; Glenn Woning, MD; Margaret E. Wierman, MD; Mary E. Plomondon, PhD; John S. Rumsfeld, MD, PhD; P. Michael Ho, MD, PhD
1The University of Texas at Southwestern Medical Center, Dallas
2VA Eastern Colorado Health Care System, Denver3University of Colorado Denver, Aurora
2VA Eastern Colorado Health Care System, Denver3University of Colorado Denver, Aurora4Colorado Cardiovascular Outcomes Research (CCOR) Consortium, Denver
3University of Colorado Denver, Aurora
JAMA. 2013;310(17):1829-1836. doi:10.1001/jama.2013.280386.
March 5, 2014
Daniel M. Riche, PharmD; William L. Baker, PharmD; Christian A. Koch, MD, PhD
1Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson
2Department of Pharmacy Practice, University of Connecticut, Storrs
3Division of Endocrinology, University of Mississippi Medical Center, Jackson
JAMA. 2014;311(9):963-964. doi:10.1001/jama.2014.386.
March 5, 2014
Sandeep Dhindsa, MBBS; Manav Batra, MBBS; Paresh Dandona, MBBS
1Division of Endocrinology and Metabolism, Texas Tech University Health Sciences Center, Odessa
2Division of Endocrinology and Metabolism, State University of New York, Buffalo
JAMA. 2014;311(9):964. doi:10.1001/jama.2014.389.
March 5, 2014
Abraham Morgentaler, MD; Abdulmaged Traish, PhD; Ravi Kacker, MD
1Harvard Medical School, Boston, Massachusetts
2Division of Urology, Boston University School of Medicine, Boston, Massachusetts
JAMA. 2014;311(9):961-962. doi:10.1001/jama.2014.392.
March 5, 2014
James Katz, MD, MPH; Robert Nadelberg, MD
1Age Management Boston, Boston, Massachusetts
JAMA. 2014;311(9):963. doi:10.1001/jama.2014.395.
March 5, 2014
T. Hugh Jones, BSc, MD, FRCP; Kevin S. Channer, MD, FRCP
1Robert Hague Centre for Diabetes and Endocrinology, Barnsley Hospital NHS Foundation Trust, Barnsley, England
2Sheffield Hallam University, Sheffield, England
JAMA. 2014;311(9):962-963. doi:10.1001/jama.2014.398.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...